Five Prime Therapeutics, Inc. (FPRX): Price and Financial Metrics
Five Prime Therapeutics, Inc. (FPRX)
Today's Latest Price: $15.17 USD
Updated Jan 26 6:55pm
Add FPRX to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
FPRX Stock Summary
- The capital turnover (annual revenue relative to shareholder's equity) for FPRX is 0.18 -- better than only 16.36% of US stocks.
- With a price/sales ratio of 33.75, Five Prime Therapeutics Inc has a higher such ratio than 92.62% of stocks in our set.
- The volatility of Five Prime Therapeutics Inc's share price is greater than that of 96.69% US stocks with at least 200 days of trading history.
- Stocks that are quantitatively similar to FPRX, based on their financial statements, market capitalization, and price volatility, are SURF, NVCN, XFOR, DCPH, and FOLD.
- Visit FPRX's SEC page to see the company's official filings. To visit the company's web site, go to www.fiveprime.com.
FPRX Stock Price Chart Interactive Chart >
FPRX Price/Volume Stats
| Current price | $15.17 | 52-week high | $24.70 |
| Prev. close | $15.75 | 52-week low | $1.75 |
| Day low | $15.06 | Volume | 708,000 |
| Day high | $16.10 | Avg. volume | 1,152,031 |
| 50-day MA | $17.67 | Dividend yield | N/A |
| 200-day MA | $8.12 | Market Cap | 577.04M |
Five Prime Therapeutics, Inc. (FPRX) Company Bio
Five Prime Therapeutics discovers and develops innovative therapeutics to improve the lives of patients with serious diseases. The company was founded in 2001 and is based in South San Francisco, California.
Loading social stream, please wait...